Q: Retired, dividend-income investor.
I've held Alaris just about forever and the current AD.UN iteration since 2018...bought in the $12 range. It has been on a bit of a run lately and hit $20 today. It is now in the asset allocation range I usually reserve for blue chip companies....instead of a smaller allocation reserved for smaller, higher risk companies.
With their portfolio of partner companies, I have also considered Alaris as almost ETF-like. I break out their holdings into the various asset allocation sectors, while maintaining a 50% weight in financials.
Q#1 = related to their valuations (P/B, P/CF, P/S, P/E), is Alaris on the cheap or expensive side?
Q#2 = do you agree with my thinking, that AD is almost ETF-like? If so, then I can live with the slightly higher asset allocation. If not, then I could comfortably trim and reallocate the proceeds.
Any comments would be appreciated. Thanks for your help...Steve
I've held Alaris just about forever and the current AD.UN iteration since 2018...bought in the $12 range. It has been on a bit of a run lately and hit $20 today. It is now in the asset allocation range I usually reserve for blue chip companies....instead of a smaller allocation reserved for smaller, higher risk companies.
With their portfolio of partner companies, I have also considered Alaris as almost ETF-like. I break out their holdings into the various asset allocation sectors, while maintaining a 50% weight in financials.
Q#1 = related to their valuations (P/B, P/CF, P/S, P/E), is Alaris on the cheap or expensive side?
Q#2 = do you agree with my thinking, that AD is almost ETF-like? If so, then I can live with the slightly higher asset allocation. If not, then I could comfortably trim and reallocate the proceeds.
Any comments would be appreciated. Thanks for your help...Steve
5i Research Answer:
Compared to historicals, valuation (P/E) is on the cheap side. Other metrics as well are lower...